SONIA EVANS: Open Payments
NPI 1518473149 · WARNER ROBINS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$645 in 34 payments from 11 companies in 2025. Trend: 2023 $1,472 · 2024 $959 · 2025 $645
Food & beverage: $645
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $140 |
| Amgen Inc. | 6 | $118 |
| Novo Nordisk Inc | 5 | $109 |
| Lilly USA, LLC | 5 | $87 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| PFIZER INC. | 2 | $37 |
| Esperion Therapeutics, Inc. | 2 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: Wegovy, EVENITY, FARXIGA, ZEPBOUND, REXULTI, PREVNAR 20, MOUNJARO, AIRSUPRA.
Industry payments across GA — which companies pay providers there.
